AMYRA is developing therapeutic product applications for the treatment of celiac disease and gluten sensitivity, which represent major public health issues. Both conditions are triggered by the ingestion of gluten in genetically predisposed people. Gluten is ubiquitously present in the Western diet and thus almost impossible to avoid.


Malzgasse 9, 4052 Basel, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation